Literature DB >> 31839333

Evaluation of dengue serological tests available in Puerto Rico for identification of prior dengue infection for prevaccination screening.

Matthew Bonaparte1, James Huleatt2, Shekema Hodge3, Lingyi Zheng4, Yaniv Lustig5, Carlos A DiazGranados6, Yasemin Ataman-Önal7, Stephen Savarino8.   

Abstract

We assessed a dengue IgG rapid diagnostic test (RDT) and IgG enzyme-linked immunosorbent assay (ELISA) to determine their suitability for dengue prevaccination screening. Each exhibited ≥99% specificity. The RDT demonstrated no Zika cross-reactivity, while the ELISA displayed greater sensitivity. Both could safely guide vaccination in Puerto Rico pending availability of improved serotests.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CYD-TDV; Cross-reactivity; Dengue serostatus; Dengvaxia; Flaviviruses; Prevaccination screening; Prior dengue infection; Sensitivity; Specificity

Year:  2019        PMID： 31839333     DOI： 10.1016/j.diagmicrobio.2019.114918

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  2 in total

1.  Performance Evaluation of a Dengue IgG Rapid Diagnostic Test Designed to Determine Dengue Serostatus as Part of Prevaccination Screening.

Authors:  Vasco Liberal; Remi Forrat; Cong Zhang; Charles Pan; Matthew Bonaparte; Wushan Yin; Lingyi Zheng; Valeria Viscardi; Yukun Wu; Yasemin Ataman-Önal; Stephen Savarino; Catherine Chen
Journal:  Microbiol Spectr       Date:  2022-05-23

2.  Determining dengue virus serostatus by indirect IgG ELISA compared with focus reduction neutralisation test in children in Cebu, Philippines: a prospective population-based study.

Authors:  Anna Lena Lopez; Cameron Adams; Michelle Ylade; Ramesh Jadi; Jedas Veronica Daag; Caitlyn T Molloy; Kristal An Agrupis; Deok Ryun Kim; Maria Wilda Silva; In-Kyu Yoon; Laura White; Jacqueline Deen; Aravinda M de Silva
Journal:  Lancet Glob Health       Date:  2020-11-16       Impact factor: 38.927
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.